VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 132 filers reported holding VBI VACCINES INC in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $976 | -25.0% | 3,222,101 | -3.1% | 0.01% | -28.6% |
| Q4 2022 | $1,301 | -99.9% | 3,326,821 | +6.2% | 0.01% | -41.7% |
| Q3 2022 | $2,211,000 | +22.4% | 3,132,545 | +40.3% | 0.01% | +20.0% |
| Q2 2022 | $1,806,000 | -50.3% | 2,233,150 | +2.0% | 0.01% | -41.2% |
| Q1 2022 | $3,635,000 | -27.6% | 2,189,700 | +2.0% | 0.02% | -22.7% |
| Q4 2021 | $5,023,000 | -21.8% | 2,146,508 | +3.9% | 0.02% | -31.2% |
| Q3 2021 | $6,425,000 | -1.4% | 2,065,953 | +6.2% | 0.03% | +3.2% |
| Q2 2021 | $6,515,000 | +18.4% | 1,944,773 | +9.9% | 0.03% | +3.3% |
| Q1 2021 | $5,504,000 | +21.7% | 1,769,848 | +7.6% | 0.03% | +15.4% |
| Q4 2020 | $4,524,000 | -13.8% | 1,645,030 | -10.4% | 0.03% | -25.7% |
| Q3 2020 | $5,249,000 | -1.3% | 1,835,353 | +7.0% | 0.04% | -12.5% |
| Q2 2020 | $5,316,000 | +227.3% | 1,714,744 | +0.3% | 0.04% | +150.0% |
| Q1 2020 | $1,624,000 | -31.4% | 1,709,592 | -0.4% | 0.02% | -11.1% |
| Q4 2019 | $2,368,000 | +209.1% | 1,716,103 | +5.6% | 0.02% | +157.1% |
| Q3 2019 | $766,000 | -54.5% | 1,625,163 | +13.1% | 0.01% | -53.3% |
| Q2 2019 | $1,682,000 | -33.1% | 1,437,549 | +6.9% | 0.02% | -37.5% |
| Q1 2019 | $2,514,000 | +16.8% | 1,344,619 | -0.0% | 0.02% | 0.0% |
| Q4 2018 | $2,152,000 | -35.0% | 1,345,101 | -1.7% | 0.02% | -25.0% |
| Q3 2018 | $3,311,000 | -7.5% | 1,368,021 | +5.1% | 0.03% | -15.8% |
| Q2 2018 | $3,579,000 | -26.5% | 1,301,473 | -6.5% | 0.04% | -30.9% |
| Q1 2018 | $4,870,000 | -19.8% | 1,391,417 | -2.2% | 0.06% | -22.5% |
| Q4 2017 | $6,074,000 | +11.4% | 1,422,499 | +0.5% | 0.07% | -2.7% |
| Q3 2017 | $5,450,000 | -9.1% | 1,415,650 | +2.7% | 0.07% | -17.0% |
| Q2 2017 | $5,994,000 | -20.8% | 1,377,990 | +0.0% | 0.09% | -31.8% |
| Q1 2017 | $7,564,000 | +76.2% | 1,377,834 | -0.5% | 0.13% | +61.2% |
| Q4 2016 | $4,292,000 | -9.2% | 1,384,376 | +0.4% | 0.08% | -9.1% |
| Q3 2016 | $4,728,000 | +15.0% | 1,378,351 | +32.4% | 0.09% | +1.1% |
| Q2 2016 | $4,111,000 | – | 1,040,690 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 55,042,465 | $171,182,000 | 2.49% |
| GENERAL AMERICAN INVESTORS CO INC | 1,877,497 | $5,839,000 | 0.50% |
| HighVista Strategies LLC | 41,271 | $129,000 | 0.08% |
| ArchPoint Investors | 65,000 | $202,000 | 0.06% |
| FIRST MIDWEST BANK TRUST DIVISION | 136,714 | $425,000 | 0.06% |
| FNY Investment Advisers, LLC | 24,683 | $76,000 | 0.04% |
| GRIMES & COMPANY, INC. | 257,960 | $802,000 | 0.04% |
| Cambridge Investment Research Advisors, Inc. | 2,065,953 | $6,425,000 | 0.03% |
| Ergoteles LLC | 171,127 | $532,000 | 0.02% |
| J.W. COLE ADVISORS, INC. | 71,100 | $221,000 | 0.02% |